Dana-Faber Cancer Institute, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dana-Faber Cancer Institute, Inc..The latest application filed is for "methods for identification, assessment, prevention, and treatment of metabolic disorders using slit2".

Company Profile

5.9.3

Dana-Faber Cancer Institute, Inc. - Boston MA
Dana-Faber Cancer Institute, Inc. - N/A

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treating cancer deficient in FANCA, FANCD2, FANCE, or FANCG with an ATM inhibitor Grant 10,738,310 - D'Andrea , et al. A	2020-08-11
Calmodulin Inhibitors, Chk2 Inhibitors And Rsk Inhibitors For The Treatment Of Ribosomal Disorders And Ribosomapathies App 20190314374A1 -	2019-10-17
Vaccine compositions and methods for restoring NKG2D pathway function against cancers Grant 10,279,021 - Dranoff , et al.	2019-05-07
Systems, apparatus, and methods related to magnetically-controlled three-dimensional tissue cultures Grant 10,221,381 - Dhimolea , et al.	2019-03-05
Methods For Identification, Assessment, Prevention, And Treatment Of Metabolic Disorders Using Slit2 App 20180193416 - Spiegelman; Bruce M. ; et al.	2018-07-12
Conformationally stabilized HIV envelope immunogens Grant 8,715,686 - Kwong , et al. May 6, 2	2014-05-06
Methods Of Treating A Meiotic Kinesin Associated Disease App 20140106344 - Pellman; David	2014-04-17
Psoriasin expression by breast epithelial cells Grant 7,776,541 - Polyak , et al. August 17, 2	2010-08-17
Aplidine for multiple myeloma treatment Grant 7,381,703 - Bertino , et al. June 3, 2	2008-06-03
T cell costimulatory polypeptides containing alternative domains Grant 7,153,934 - Sharpe , et al. December 26, 2	2006-12-26
B7-4 polypeptides and uses therefor Grant 7,038,013 - Freeman , et al. May 2, 2	2006-05-02
Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily Grant 5,316,920 - Tedder , et al. May 31, 1	1994-05-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.